Efficacy and safety of Infliximab for steroid-resistant immune-related adverse events: A retrospective study.

Autor: Kadokawa, Yukio1 (AUTHOR) kadocchi41@gmail.com, Takagi, Mari1 (AUTHOR), Yoshida, Tomoe1 (AUTHOR), Tatsumi, Akitoshi2 (AUTHOR), Fujita, Keiko1 (AUTHOR), Inoue, Takako3 (AUTHOR), Ohe, Shuichi4 (AUTHOR), Nakai, Yasutomo5 (AUTHOR), Yamamoto, Sachiko6 (AUTHOR), Otsuka, Tomoyuki7 (AUTHOR), Ishihara, Ryu6 (AUTHOR), Isei, Taiki4 (AUTHOR), Kumagai, Toru3 (AUTHOR), Nishimura, Kazuo5 (AUTHOR), Imamura, Fumio7 (AUTHOR)
Zdroj: Molecular & Clinical Oncology. Apr2021, Vol. 14 Issue 4, pN.PAG-N.PAG. 1p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje